Research Site

Xining 810007

1 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Chronic Obstructive Pulmonary Disease, Gastroesophageal Junction Adenocarcinoma, HER2-positive Gastric Cancer, Non Small Cell Lung Cancer NSCLC

Studies at this site

• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy — Recruiting now
• A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer — Recruiting now
• Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). — Running, not enrolling
• Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD — Completed